140 related articles for article (PubMed ID: 8626540)
21. Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus.
O'Brien JS; Kretz KA; Dewji N; Wenger DA; Esch F; Fluharty AL
Science; 1988 Aug; 241(4869):1098-101. PubMed ID: 2842863
[TBL] [Abstract][Full Text] [Related]
22. Nucleotide sequence of cloned cDNA for human sphingolipid activator protein 1 precursor.
Dewji NN; Wenger DA; O'Brien JS
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8652-6. PubMed ID: 2825202
[TBL] [Abstract][Full Text] [Related]
23. The precursor of sulfatide activator protein is processed to three different proteins.
Fürst W; Machleidt W; Sandhoff K
Biol Chem Hoppe Seyler; 1988 May; 369(5):317-28. PubMed ID: 3048308
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts.
Fujibayashi S; Wenger DA
J Biol Chem; 1986 Nov; 261(32):15339-43. PubMed ID: 3771578
[TBL] [Abstract][Full Text] [Related]
25. Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat Sertoli cells: sequence similarity with the 70-kilodalton precursor to sulfatide/GM1 activator.
Collard MW; Sylvester SR; Tsuruta JK; Griswold MD
Biochemistry; 1988 Jun; 27(12):4557-64. PubMed ID: 3048385
[TBL] [Abstract][Full Text] [Related]
26. Sulfatide activator protein. Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease.
Holtschmidt H; Sandhoff K; Kwon HY; Harzer K; Nakano T; Suzuki K
J Biol Chem; 1991 Apr; 266(12):7556-60. PubMed ID: 2019586
[TBL] [Abstract][Full Text] [Related]
27. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
28. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
Sandhoff K; Kolter T; Van Echten-Deckert G
Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348
[TBL] [Abstract][Full Text] [Related]
29. Analysis of recombinant human saposin A expressed by Pichia pastoris.
Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
[TBL] [Abstract][Full Text] [Related]
30. Role of sphingolipids in the transport of prosaposin to the lysosomes.
Lefrancois S; Michaud L; Potier M; Igdoura S; Morales CR
J Lipid Res; 1999 Sep; 40(9):1593-603. PubMed ID: 10484606
[TBL] [Abstract][Full Text] [Related]
31. Activator proteins and topology of lysosomal sphingolipid catabolism.
Fürst W; Sandhoff K
Biochim Biophys Acta; 1992 Jun; 1126(1):1-16. PubMed ID: 1606169
[TBL] [Abstract][Full Text] [Related]
32. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins.
Linke T; Wilkening G; Sadeghlar F; Mozcall H; Bernardo K; Schuchman E; Sandhoff K
J Biol Chem; 2001 Feb; 276(8):5760-8. PubMed ID: 11104761
[TBL] [Abstract][Full Text] [Related]
33. Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.
Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Barca A; Scerch C
J Biol Chem; 1997 Jul; 272(27):16862-7. PubMed ID: 9201993
[TBL] [Abstract][Full Text] [Related]
34. Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP).
Hiesberger T; Hüttler S; Rohlmann A; Schneider W; Sandhoff K; Herz J
EMBO J; 1998 Aug; 17(16):4617-25. PubMed ID: 9707421
[TBL] [Abstract][Full Text] [Related]
35. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
[TBL] [Abstract][Full Text] [Related]
36. Sphingolipid activator proteins: proteins with complex functions in lipid degradation and skin biogenesis.
Schuette CG; Pierstorff B; Huettler S; Sandhoff K
Glycobiology; 2001 Jun; 11(6):81R-90R. PubMed ID: 11445546
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
38. Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy.
Rafi MA; Zhang XL; DeGala G; Wenger DA
Biochem Biophys Res Commun; 1990 Jan; 166(2):1017-23. PubMed ID: 2302219
[TBL] [Abstract][Full Text] [Related]
39. Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C.
Fujibayashi S; Wenger DA
Clin Chim Acta; 1985 Mar; 146(2-3):147-56. PubMed ID: 3921288
[TBL] [Abstract][Full Text] [Related]
40. Mouse testicular sulfated glycoprotein-1: sequence analysis of the common backbone structure of prosaposins.
Zhao Q; Bell AW; El-Alfy M; Morales CR
J Androl; 1998; 19(2):165-74. PubMed ID: 9570739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
